Table 1.
Short overview of commonly used siRNA drug-delivery systems
| Type | Examples |
|---|---|
| Drug conjugates | Antibody-siRNA conjugates, polymer-siRNA conjugates, GalNAc-siRNA conjugates, cholesterol-siRNA conjugates |
| Lipid-based nanocarriers | Liposomes, stealth liposomes, solid-lipid nanoparticles, stable nucleic acid lipid particles, lipid nanoparticles |
| Polymeric nanocarriers | Nanoparticles based on degradable or non-degradable polymers [chitosan, cyclodextrine, poly(ethylene imine), poly(L-lysine), poly(beta-amino-ester)]; dendrimers [poly(propylene imine), poly(amidoamine)] |
| Inorganic nanocarriers | Silica nanoparticles, metal/metal oxide nanoparticles (Au, FexOy) |
| Others | Carbon-based nanoparticles, hydrogels, quantum dots, natural ECVs (exosomes, larger ECVs) |
ECVs extracellular vesicles, GalNAc N-acetylgalactosamine, siRNA small interfering RNA